Though news is spreading about the lockdown restrictions being relaxed across the world, no vaccine or cure for the COVID-19 Novel Corona Virus has been found yet! There are more than 110 vaccines in various stages of trials in different countries but none of them are in the final stages of mass production. We have now received a very positive piece of news on a vaccine, which is being developed by the American biotechnology giant Moderna! The phase 1 trials of this vaccine was conducted with 45 participants but the company is looking to enroll about 600 participants for the phase 2 trials!

Phase 2 Human trials begin for Moderna COVID vaccine

The Phase 1 trials are conducted to check the safety of a vaccine in humans while the phase 2 gauge the effectiveness and provide more data on the safety levels! This mRNA-1273 vaccine was selected by Moderna in association with the Vaccine Research Centre (VRC) at the National Institute of Allergy & Infectious Diseases (NIAID), which is a part of the US National Institutes of Health (NIH)! Following the announcement of the Phase 2 trials, stocks of Moderna have soared by over 20% and there is an overall positive buzz around this vaccine. If everything goes well, the Phase 3 trials are expected to get underway by July! Stay tuned for updates...